David Maron
Dr. David Maron is a preventive cardiologist at Stanford University, known for his expertise in cholesterol management and cardiovascular disease. He has been instrumental in researching lipoprotein(a) and its implications for heart health, emphasizing the importance of testing for this genetic risk factor. Maron recently commented on the promising results of an experimental drug, lepodisiran, indicating its potential to significantly lower Lp(a) levels and possibly reduce the risk of heart attacks.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Brazil | 1 | 8.00 | 0.04% | +0% | 211,049,527 | 88,416 | $1,500,000 | 628$ |
| Totals | 1 | 211,049,527 | 88,416 | $1,500,000 | 628$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Brazil:
David Maron is a preventive cardiologist who commented on the exciting evidence of deep and lasting reduction in lipoprotein levels with lepodisiran.
8